Publication date: January 16, 2026

Pharmaceutical production is one of the most regulated activities in Poland, Europe, and globally. The reason seems obvious: creating drugs can cause numerous complications, health problems, and in extreme cases, even death, depending on the individual patient’s health contraindications. Due to the above-mentioned reasons, the process of creating a new drug is often very expensive and lengthy, and involves a large number of professionals and scientists specializing in this field. In an era of dynamic digitalization, the need to develop specific operational rules for drug production and principles for using AI (Artificial Intelligence) and ML (Machine Learning) models is increasingly emphasized. Manufacturers are often considering implementing AI systems to support pharmaceutical production processes.

More

Publication date: November 12, 2025

Artificial intelligence (AI) is currently finding widespread use in healthcare. A prime example is the Polish National Health Fund (NFZ) initiative, which utilizes AI to analyze patient data stored in the Fund’s databases. This data is then analyzed with the support of machine learning tools to make strategic decisions regarding the health of Poles. This approach will certainly simplify the work of doctors by searching for and analyzing the desired information, undoubtedly reducing their workload. However, such a solution may raise several issues and legal requirements related to regulations regarding the protection and processing of personal data.

More